Abstract
Abstract
Background
Growing antibiotic resistance demands the constant reassessment of antimicrobial efficacy, particularly in countries with wide antibiotic abuse, where higher resistance prevalence is often found. Knowledge of resistance trends is particularly important when prescribing antibiotics empirically, as is usually the case for urinary tract infections (UTIs). Currently, in Mexico City, ampicillin, cotrimoxazole (trimethoprim/sulfamethoxazole), and ciprofloxacin are used as “first-line” antibiotic treatment for UTI.
Objective
The aim of this study was to analyze the resistance of bacterial isolates to antibiotics, with a focus on first-line antibiotics, in Mexican pediatric patients and sexually active or pregnant female outpatients.
Methods
In this multicenter susceptibility analysis, bacterial isolates from urine samples collected from pediatric patients and sexually-active or pregnant female outpatients presenting with acute, uncomplicated UTIs in Mexico City from January 2006 through June 2006, were included in the study. Samples were tested for susceptibility to 10 antibiotics by the disk-diffusion method.
Results
Four-hundred and seventeen bacterial isolates were derived from sexually active or pregnant female outpatients (324 Escherichia coli) and pediatric patients (93 Klebsiella pneumoniae). We found a high prevalence of resistance towards the drugs used as “first-line” when treating UTIs: ampicillin, cotrimoxazole, and ciprofloxacin (79%, 60%, and 24% resistance, respectively). Ninety-eight percent of K pneumoniae isolates were resistant to ampicillin, whereas 66% of the E coli isolates were resistant to cotrimoxazole. Resistance towards third-generation cephalosporins was also high (6%–8% of E coli and 10%–28% of K pneumoniae). This was possibly caused by chromosomal β-lactamases, as 30% of all isolates were also resistant to amoxicillin/clavulanate. In contrast, 98% of the E coli isolates and 84% of the K pneumoniae strains (96% of all isolates) were found to be susceptible to nitrofurantoin, which has been in clinical use for much longer than most other drugs in this study.
Conclusion
In these urine samples from laboratories in Mexico City, resistance of K pneumoniae and E coli isolates to first-line treatment (ampicillin, cotrimoxazole, or ciprofloxacin) of UTI was high, whereas most E coli and K pneumoniae isolates were susceptible to nitrofurantoin and the fourth-generation cephalosporin cefepime. (Curr Ther Res Clin Exp. 2007;68:120–126) Copyright © 2007 Excerpta Medica, Inc.
Key Words: urinary tract infection, uropathogenic bacteria
Full Text
The Full Text of this article is available as a PDF (92.1 KB).
References
- 1.Davies J, Amábile-Cuevas CF. The rise of antibiotic resistance. In: Amábile-Cuevas CF, editor. Multiple Drug Resistant Bacteria. Horizon Scientific Press; Norfolk, UK: 2003. pp. 1–7. [Google Scholar]
- 2.O'Brien TF, Stelling JM. Monitoring antimicrobial resistance. In: Amábile-Cuevas CF, editor. Antimicrobial Resistance in Bacteria. Horizon Bioscience; Norfolk, UK: 2006. pp. 123–148. [Google Scholar]
- 3.Albrich WC, Monnet DL, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis. 2004;38(Suppl 4):S363–S371. doi: 10.3201/eid1003.030252. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Amábile-Cuevas CF, Cabrera R, Fuchs LY. Antibiotic resistance and prescription practices in developing countries. In: Williams P, Ketley J, Salmond G, editors. Methods in Microbiology, Vol. 27: Bacterial Pathogenesis. Academic Press Inc; San Diego, Calif: 1998. pp. 587–594. [Google Scholar]
- 5.Levy SB. Plenum Press; New York, NY: 1992. The Antibiotic Paradox. [Google Scholar]
- 6.Shigei J. Test methods used in the identification of commonly isolated aerobic gramnegative bacteria. In: Isenberg HD, editor. Clinical Microbiology Procedures Handbook. American Society for Microbiology; Washington, DC: 1992. pp. 1.19.1–1.19.111. [Google Scholar]
- 7.Clinical Laboratory Standards Institute (CLSI) 9th ed. CLSI; Wayne, Pa: 2006. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard. [Google Scholar]
- 8.Lopardo G, Fridman D, Gonzalez Arzac M. Uropathogen resistance: Are laboratory-generated data reliable enough? J Chemother. 2007;19:33–37. doi: 10.1179/joc.2007.19.1.33. [DOI] [PubMed] [Google Scholar]
- 9.Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: The ECO.SENS project. J Antimicrobial Chemother. 2003;51:69–76. doi: 10.1093/jac/dkg028. [DOI] [PubMed] [Google Scholar]
- 10.Karlowsky JA, Jones ME, Thornsberry C. Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999. Int J Antimicrobial Agents. 2001;18:121–127. doi: 10.1016/s0924-8579(01)00369-7. [DOI] [PubMed] [Google Scholar]
- 11.Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999;281:736–738. doi: 10.1001/jama.281.8.736. [DOI] [PubMed] [Google Scholar]
- 12.Levy Hara G, Sosa A. Resistencia en los principales uropatógenos y su impacto en la decisión terapéutica. In: Levy Hara G, Sosa A, editors. Uso y Abuso de los Antibióticos. Arena; Montevideo, Uruguay: 2006. pp. 71–79. [Google Scholar]
- 13.Calva JJ, Niebla-Pérez A, Rodríguez-Lemoine V. Antibiotic usage and antibiotic resistance in Latin America. In: Amábile-Cuevas CF, editor. Antibiotic Resistance: From Molecular Basics to Therapeutic Options. Chapman & Hall; New York, NY: 1996. pp. 73–97. [Google Scholar]
- 14.Köhler T, Pechere JC. Bacterial resistance to quinolones, mechanisms and clinical implications. In: Andriole VT, editor. The Quinolones. 2nd ed. Academic Press; San Diego, Calif: 1998. pp. 117–142. [Google Scholar]
- 15.Oliver A, Canton R, Campo P. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science. 2000;288:1251–1254. doi: 10.1126/science.288.5469.1251. [DOI] [PubMed] [Google Scholar]
- 16.Kucers A, Crowe S, Grayson ML, Hay J. 5th ed. Butterworth-Heinemann; Oxford, UK: 1997. The Use of Antibiotics: Clinical Review of Antibacterial, Antifungal and Antiviral Drugs. [Google Scholar]